VERGELLI, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 3.526
NA - Nord America 2.906
AS - Asia 470
AF - Africa 20
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.928
Nazione #
US - Stati Uniti d'America 2.900
PL - Polonia 1.867
RU - Federazione Russa 558
IT - Italia 265
SE - Svezia 241
IE - Irlanda 240
SG - Singapore 142
HK - Hong Kong 131
GB - Regno Unito 86
CN - Cina 81
UA - Ucraina 77
DE - Germania 70
FI - Finlandia 59
IN - India 42
VN - Vietnam 35
JO - Giordania 25
BE - Belgio 23
CI - Costa d'Avorio 14
ES - Italia 13
FR - Francia 12
TR - Turchia 12
NL - Olanda 7
CA - Canada 6
BR - Brasile 5
SC - Seychelles 4
CH - Svizzera 3
RO - Romania 3
EG - Egitto 2
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EU - Europa 1
JP - Giappone 1
TW - Taiwan 1
Totale 6.928
Città #
Warsaw 1.866
Fairfield 445
Chandler 289
Dublin 239
Seattle 218
Ashburn 216
Cambridge 178
Woodbridge 177
Houston 153
Ann Arbor 144
Wilmington 134
Jacksonville 128
Singapore 105
Florence 102
Altamura 88
Lawrence 83
Hong Kong 81
Princeton 71
Buffalo 56
Boardman 40
Mumbai 38
Boston 37
Medford 37
Beijing 33
Dong Ket 27
San Diego 26
Shanghai 26
Brussels 22
London 20
New York 18
Moscow 17
Abidjan 14
Barcelona 13
Los Angeles 13
Hillsboro 12
Santa Clara 12
Norwalk 10
West Jordan 10
Helsinki 9
Izmir 9
Phoenix 9
Falls Church 7
Frankfurt Am Main 7
Kent 7
Milan 7
Fuzhou 5
Gavirate 5
Lappeenranta 5
Teresópolis 5
Andover 4
Napoli 4
Philadelphia 4
Tappahannock 4
Toronto 4
Auburn Hills 3
Bern 3
Esslingen am Neckar 3
Menlo Park 3
Misano Adriatico 3
Pune 3
Scandicci 3
Verona 3
Zhengzhou 3
Amsterdam 2
Carol Stream 2
Castelliri 2
Crawley 2
Dearborn 2
Leawood 2
Paris 2
Prescot 2
Redwood City 2
Rui'an 2
Salerno 2
Southwark 2
Timisoara 2
Trumbull 2
Whitechapel 2
Antwerpen 1
Atlanta 1
Bologna 1
Cairo 1
Campi Bisenzio 1
Chicago 1
Chieti 1
Clifton 1
Dallas 1
Ergolding 1
Foligno 1
Garden City 1
Guangzhou 1
Hanover 1
Hounslow 1
Istanbul 1
Laurel 1
Minsk 1
Montecatini Terme 1
Montréal 1
North Babylon 1
Ottawa 1
Totale 5.372
Nome #
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists 255
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 244
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists. 225
Synthesis and pharmacological evaluation of new pyridazin-based thioderivatives as formyl peptide receptor (FPR) agonists 217
Synthesis and evaluation as antitubercular agents of 5-arylethenyl and 5-(hetero)aryl-3-isoxazolecarboxylate 211
Synthesis and evaluation as PDE4 inhibitors of pyrimidine-2,4-dione derivatives 209
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 208
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase 200
Synthesis, enantioresolution and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. 196
Isoxazolo-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors 193
New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4-(3H)-ones fluoroderivatives as human A1 adenosine receptor ligands 176
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 175
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase 170
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. 154
Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors 142
Synthesis of five and six-membered N-phenylacetamido substituted heterocycles as formyl peptide receptor agonists 137
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. 135
Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors 132
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors 128
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold 125
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors 120
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 117
Cinnoline derivatives as human neutrophil elastase inhibitors 116
Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis. 112
New pyrazolo[1',5':1,6]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors 107
4-AMINO-3(2H)-PYRIDAZINONES BEARING ARYLPIPERAZINYLALKYL GROUPS AND RELATED COMPOUNDS: SYNTHESIS AND ANTINOCICEPTIVE ACTIVITY 107
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 106
4-Amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action 104
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action 104
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 97
SELECTIVE ACAT INHIBITORS AS PROMISING ANTIHYPERLIPIDEMIC, ANTIATHEROSCLEROTIC AND ANTI-ALZHEIMER DRUGS 96
ISOXAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS LEISHMANIA MEXICANA PDE INHIBITORS 96
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: synthesis and evaluation of their phosphodiesterase 4 inhibitory activity 96
4-amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: synthesis, SARs, and preliminary studies on the mechanism of action 95
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase 95
6-Methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors. 92
AIRWAY RELAXANT AND ANTI-INFLAMMATORY PROPERTIES OF A PDE 4 INHIBITOR WITH LOW AFFINITY FOR THE HIGH-AFFINITY ROLIPRAM BINDING SITE 89
NOVEL 3-ARYLAMINO- AND 3-CYCLOALKYLAMINO-5,6-DIPHENYLPYRIDAZINES ACTIVE AS ACAT INHIBITORS 88
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 85
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. 83
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 80
PDE5 Inhibitors and their applications 78
New 3,6-disubstituted pyrazolo[1,5-a]quinazolines as ligands to GABAA receptor subtype 74
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A1 adenosine receptor ligands 73
Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic study 73
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors 68
4-amino-5-vinyl-3(2H)-pyridazinones and related compounds: synthesis and evaluation of antinociceptive activity 63
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis 60
'Proximity frequencies' a new parameter to evaluate the profile of GABAAR modulators 59
Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity agents as potential agents for treatment of erectile dysfunction 59
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists 59
SYNTHESIS AND EVALUATION OF SOME PYRAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS PDE5 INHIBITORS POTENTIALLY USEFUL AS PERIPHERAL VASODILATOR 56
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors 56
preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 53
Preparation of pyridazin-3(2H)-ones and their use as PDE4 inhibitors 53
Synthesis and evaluation of novel pyrrolo[2,3-d] and thieno[2,3-d]pyridazinones as in vitro antiproliferative agents 51
Preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 50
NEW SYNTHESIS OF DIFFERENTLY FUSED PYRIDAZINONQUINOLINES 48
Molecular manipulation of the 1,5,6,7-tetrahydro-4 H -indazol-4-one scaffold to obtain new human neutrophil elastase (HNE) inhibitors 48
Alpha-2-agonist as analgesic agents 47
Pyridazin-3(2H)-one derivatives as novel PDE IV inhibitors 36
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets 35
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis 31
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABAA Receptor Subtype 29
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis 26
GABAA receptor modulators with a pyrazolo[1,5-a]quinazoline core: synthesis, molecular modelling studies and electrophysiological assay 25
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 23
New quinoline-based PDE4 inhibitors through GSK-256066 fragment-based elaboration 22
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors 22
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity 14
Totale 7.108
Categoria #
all - tutte 19.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.811


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.049 0 0 0 105 162 147 126 170 116 86 108 29
2020/20211.088 91 89 34 117 59 123 70 82 126 178 46 73
2021/2022508 16 34 40 17 17 32 17 36 20 39 121 119
2022/20231.232 123 271 47 102 99 207 153 65 99 5 42 19
2023/2024405 12 48 81 22 22 54 12 96 8 27 16 7
2024/2025820 123 324 173 200 0 0 0 0 0 0 0 0
Totale 7.108